Q2 2025 Oriola Oyj Earnings Call Transcript
Key Points
- Oriola Corp (OHEL:ORIOLA) achieved a 12% growth in net sales, reaching EUR494 million, driven by strong partnerships and customer centricity.
- The distribution segment saw an 11% net sales growth, particularly strong in Sweden, with an adjusted EBITDA improvement to EUR8.3 million from EUR6.1 million last year.
- The wholesale segment experienced an 18% growth in net sales, driven by the parallel imported segment in Sweden.
- Oriola Corp (OHEL:ORIOLA) has been approved by the Science Based Targets initiative, committing to significant reductions in greenhouse gas emissions by 2050.
- The company has implemented strict cost control measures, including a recruitment freeze, to enhance profitability and efficiency.
- The joint venture company Kronans Apotek reported disappointing results, with an EBITDA of minus EUR2.6 million compared to EUR0.6 million last year.
- Adjusted EBITDA for the wholesale segment declined to EUR2.1 million from EUR3.1 million last year, due to an unfavorable product mix and increased costs.
- Oriola Corp (OHEL:ORIOLA) faced higher costs in the distribution segment due to temporary storage capacity constraints and high peaks in ordering.
- The company is burdened by significant costs related to the ERP project and other adjusting items, impacting net income.
- Consumer confidence remains weak in Finland and Sweden, affecting the self-care segment, with a shift towards cheaper products.
Good morning, everyone, and a warm welcome to Oriola's Q2 results webcast. My name is [Duosteoel] and I'm from Morelos Investor Relations. With me today I have our CEO, Katarina Gabrielson and CFO, Mats Danielsson.
And after the presentation, we will open up for your questions and you can start to send in your questions already during the presentations. Please be aware that we will focus on questions relating to Oriola's business and financial development and take questions on Kronans Apotek only within a limited scope.
We are recording this webcast, and the recording will be available on our website later today. And next we have the disclaimer that we all should be aware of. And without further to do, Katarina, please go ahead.
Thank you, Tua. And then you can see the agenda for today. We will start as normally with the quarter 2 highlights, going via the operating environment and segments to the financial review and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
